earn	cooper development bugs restates results cooper development revised results for year ended october loss mln dlrs dlrs per share previously reported loss mln dlrs cts per share restatement made change method accounting for combination company controlled concerns that resulted mln dlr charge cooper development last august cooper development combined cooper biomedical inc unit and cooper laboratories subsidiary technicon instruments corp company acquired revlon inc rev cooper spokesman spokesman transaction accounted for acquisition securities and exchange commission issue accounting method and accounted for reorganization entities common control this treatment requires that costs associated transaction expanded capitalized intangible asset company that since charged required expensing previously accrued liabilities company will experience resulting material change cash flow InformationRetrieval.reuter